Regenerative Therapies for Diabetic Microangiopathy
Table 2
Overview of the experimental studies describing the role of stem cells in diabetic microangiopathy treatment and prevention. AD: adipose derived; BM: bone marrow; CB: cord blood; EPCs: endothelial progenitor cells; MSCs: mesenchymal stem cells; BRB: blood retinal barrier.
Complication
Cells
Outcomes
References
Neurological
CB-EPCs
Increased number of microvessels, Improved sciatic motor nerve conduction velocity, Increase of sciatic endoneurial nutritive blood flow